Ocala GI Research is a clinical research site located in Lady Lake, Florida, United States 32159.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Ocala GI Research has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD.
Sponsors: Hepion Pharmaceuticals, Inc., Cascade Pharmaceuticals, Inc.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ocala GI Research has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ocala GI Research has 2 clinical trials on record, with 1 currently active. Their work covers Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD.
Ocala GI Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.